Ariadne (psychedelic)
 | |
| Names | |
|---|---|
| IUPAC name
1-(2,5-Dimethoxy-4-methylphenyl)butan-2-amine | |
| Other names
4-Methyl-2,5-dimethoxy-alpha-ethylphenethylamine 4-Methyl-2,5-dimethoxybutanamine | |
| Identifiers | |
52842-59-8  | |
| 3D model (Jmol) | Interactive image Interactive image |
| ChemSpider | 148565 |
| PubChem | 169886 |
| |
| |
| Properties | |
| C13H21NO2 | |
| Molar mass | 223.31 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is  ?) | |
| Infobox references | |
Ariadne, 4C-D, α-Et-2C-D, BL-3912 or Dimoxamine is a lesser-known psychedelic drug. It is a homologue of 2C-D and DOM. Ariadne was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin reported testing Ariadne up to a dose of 32 mg, and reported that it produces psychedelia at a bare threshold.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Ariadne in humans apart from Shulgin's limited testing.
However, in more recent animal studies, 4C-D was shown to produce stimulus generalisation in rats trained to respond to the drug MDMA.[2] This suggests that while 4C-D may lack hallucinogenic effects, it might potentially produce empathogenic effects similar to those of MDMA if used at higher dose ranges, beyond those trialled by Shulgin (the potency of 4C-D in this study was similar to that of MDMA, 1.5 mg/kg, which would equate to a dose of ~100 mg in a human).
See also
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ Glennon RA. MDMA-Like Stimulus Effects of α-Ethyltryptamine and the α-Ethyl Homolog of DOM. Pharmacology, Biochemistry and Behaviour. 1993; 46: 459-462.